93190-53-5 Usage
Uses
Used in Fragrance Industry:
Cyclododecylacetic acid ethyl ester is used as a fragrance ingredient in perfumes and personal care products due to its pleasant fruity scent, enhancing the overall sensory experience of these products.
Used in Industrial Applications:
In the industrial sector, cyclododecylacetic acid ethyl ester serves as a solvent in certain processes, contributing to the efficiency and effectiveness of various manufacturing procedures.
Used in Adhesives and Coatings:
This chemical compound is also utilized in the formulation of specific adhesives and coatings, where it plays a role in improving the performance and quality of these products.
Despite its wide range of applications and general safety, it is crucial to follow proper handling and storage guidelines to minimize any potential health and safety risks associated with cyclododecylacetic acid ethyl ester.
Check Digit Verification of cas no
The CAS Registry Mumber 93190-53-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 9,3,1,9 and 0 respectively; the second part has 2 digits, 5 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 93190-53:
(7*9)+(6*3)+(5*1)+(4*9)+(3*0)+(2*5)+(1*3)=135
135 % 10 = 5
So 93190-53-5 is a valid CAS Registry Number.
InChI:InChI=1/C16H30O2/c1-2-18-16(17)14-15-12-10-8-6-4-3-5-7-9-11-13-15/h15H,2-14H2,1H3
93190-53-5Relevant academic research and scientific papers
Synthesis and antiallergy activity of [1,3,4]thiadiazolo[3,2-a]-1,2,3-triazolo[4,5-d]pyrimidin-9(3H)-one derivatives. II. 6-Alkyl- and 6-cycloalkylalkyl derivatives
Yokohama,Miwa,Aibara,Fujiwara,Matsumoto,Nakayama,Iwamoto,Mori,Moroi,Tsukada,Isoda
, p. 2391 - 2398 (2007/10/02)
A series of 6-alkyl- or 6-(cycloalkylalkyl)-[1,3,4]thiadiazolo[3,2-a]-1,2,3-triazolo[4,5-d]pyr imidin-9(3H)-ones 1b-o was synthesized from the corresponding 1,3,4-thiadiazol-5-amines 3b-o and the antiallergic activities of the products were evaluated. Among the compounds 6-(2-cyclohexylethyl)-[1,3,4]thiadiazolo[3,2-a]-1,2,3-triazolo[4,5-d]p yrimidin-9(3H)-one 1h, whose X-ray crystallographic stereostructure is shown, was found to be a promising new antiallergic agent, which has low toxicity and dual activity as a leukotriene D4 receptor antagonist and as an orally active mast cell stabilizer.